2020
DOI: 10.1016/j.jval.2020.04.1650
|View full text |Cite
|
Sign up to set email alerts
|

Pcn168 Medical Resource Utilization (Mru) of Apalutamide (Apa) Plus Androgen Deprivation Therapy (Adt) in Non-Metastatic Castration-Resistant Prostate Cancer (Nmcrpc) and Metastatic Castration-Sensitive Prostate Cancer (Mcspc): Results From Spartan and Titan

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles